Global Cell Line Engineering Services Supply, Demand and Key Producers, 2023-2029

Global Cell Line Engineering Services Supply, Demand and Key Producers, 2023-2029

The global Cell Line Engineering Services market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Cell line engineering services is a biotechnology service that utilizes gene editing and cell culture technologies to edit and modify cells for various research and application needs. In this service, professional scientists design suitable gene editing schemes based on the customer's requirements and use gene editing tools such as CRISPR/Cas9 to precisely modify, insert, or delete the target gene sequence. Through specific cell culture techniques, the modified cells can obtain superior phenotypes and characteristics, such as higher product yield, better growth characteristics, and higher immune response.

Cell line engineering services are mainly applied in the field of biomedicine, such as drug screening, immunotherapy, gene therapy, etc. Furthermore, since this technology can be applied to various types of cells and animal and plant cells, it can also be applied in fields such as food and agriculture, such as improving the disease resistance of some plants and improving the quality of certain meat products.

This report studies the global Cell Line Engineering Services demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cell Line Engineering Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cell Line Engineering Services that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Cell Line Engineering Services total market, 2018-2029, (USD Million)

Global Cell Line Engineering Services total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Cell Line Engineering Services total market, key domestic companies and share, (USD Million)

Global Cell Line Engineering Services revenue by player and market share 2018-2023, (USD Million)

Global Cell Line Engineering Services total market by Type, CAGR, 2018-2029, (USD Million)

Global Cell Line Engineering Services total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Cell Line Engineering Services market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CD BioSciences, Curia, Horizo​​n Discovery, Multispan, Inc., System Biosciences (SBI), Biocon, Cyagen, Analytical Biological Services (ABS) and Celvab, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cell Line Engineering Services market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Cell Line Engineering Services Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Cell Line Engineering Services Market, Segmentation by Type
Small scale
Medium scale
Large scale

Global Cell Line Engineering Services Market, Segmentation by Application
Bio-pharmaceutical
Medical Treatment
Medical Research
Others

Companies Profiled:
CD BioSciences
Curia
Horizo​​n Discovery
Multispan, Inc.
System Biosciences (SBI)
Biocon
Cyagen
Analytical Biological Services (ABS)
Celvab
Boston Institute of Biotechnology
ALSTEM
ProMab Biotechnologies
Cytosurge AG
Merck
Thermo Fisher Scientific
WuXi Advanced Therapies
GenScript Biotech Corporation (HK.1548)

Key Questions Answered

1. How big is the global Cell Line Engineering Services market?

2. What is the demand of the global Cell Line Engineering Services market?

3. What is the year over year growth of the global Cell Line Engineering Services market?

4. What is the total value of the global Cell Line Engineering Services market?

5. Who are the major players in the global Cell Line Engineering Services market?

6. What are the growth factors driving the market demand?